Comparison of Visceral Fat Reduction by Ipragliflozin and Metformin in Elderly Type 2 Diabetes Patients: Sub-Analysis of a Randomized-Controlled Study

INTRODUCTION: To compare the effects of ipragliflozin, a sodium-glucose transporter 2 inhibitor, with those of metformin on visceral fat (as well as muscles and bones) in Japanese elderly patients with type 2 diabetes (T2D), we conducted a sub-analysis of a prospective, multicenter, blinded-endpoint...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Ther
Autors principals: Koshizaka, Masaya, Ishikawa, Ko, Ishibashi, Ryoichi, Takahashi, Sho, Sakamoto, Kenichi, Yokoh, Hidetaka, Baba, Yusuke, Ide, Shintaro, Ide, Kana, Ishikawa, Takahiro, Onishi, Shunichiro, Kobayashi, Kazuki, Takemoto, Minoru, Horikoshi, Takuro, Shimofusa, Ryota, Maezawa, Yoshiro, Yokote, Koutaro
Format: Artigo
Idioma:Inglês
Publicat: Springer Healthcare 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7843837/
https://ncbi.nlm.nih.gov/pubmed/33098565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-020-00949-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars